Document is current
Any future updates will be listed below
-
Authors
Di Nardo, Lucia https://orcid.org/0000-0002-2087-7526
Pellegrini, Cristina https://orcid.org/0000-0003-2168-8097
Di Stefani, Alessandro https://orcid.org/0000-0001-8283-2633
Ricci, Francesco https://orcid.org/0000-0002-8388-9268
Fossati, Barbara https://orcid.org/0000-0002-9138-4315
Del Regno, Laura https://orcid.org/0000-0002-3692-629X
Carbone, Carmine https://orcid.org/0000-0001-5168-747X
Piro, Geny https://orcid.org/0000-0003-3708-5397
Corbo, Vincenzo https://orcid.org/0000-0002-6340-8009
Delfino, Pietro https://orcid.org/0000-0003-0119-0830
De Summa, Simona https://orcid.org/0000-0001-9607-3754
Maturo, Maria Giovanna https://orcid.org/0000-0001-8802-3220
Rocco, Tea https://orcid.org/0000-0001-7866-872X
Tortora, Giampaolo https://orcid.org/0000-0002-1378-4962
Fargnoli, Maria Concetta https://orcid.org/0000-0002-7249-2556
Peris, Ketty https://orcid.org/0000-0002-5237-0463
- License Information
-
More Information
Article History
Received: 24 January 2021
Accepted: 1 June 2021
First Online: 24 June 2021
Competing interests
: Dr. K. Peris reports grants and personal fees from Abbvie, personal fees from Almirall, personal fees from Lilly, grants and personal fees from Galderma, personal fees from Leo Pharma, personal fees from Novartis, personal fees from Pierre Fabre, from Sanofi, personal fees from Sun Pharma, personal fees from Janssen, outside the submitted work. Dr. L. Di Nardo, C. Pellegrini, A. Di Stefani, F. Ricci, B. Fossati, L. Del Regno, C. Carbone, G. Piro, V. Corbo, P. Delfino, S. De Summa, M.G. Maturo, T. Rocco, G. Tortora, M.C. Fargnoli report none conflict of interest.
